Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
News18 » Business
2-min read

Drug Firm Founder John Kapoor, Executives Convicted in US Opioid Bribery Scheme

john Kapoor’s 2017 arrest came on the same day US President Donald Trump declared the epidemic that has caused tens of thousands of overdose deaths annually a public health emergency.

Reuters

Updated:May 3, 2019, 9:57 AM IST
facebookTwitterskypewhatsapp
Drug Firm Founder John Kapoor, Executives Convicted in US Opioid Bribery Scheme
John Kapoor, the founder of Insys Therapeutics Inc. (Image: Twitter)

Boston: The founder of Insys Therapeutics Inc on Thursday became the highest-ranking pharmaceutical executive to be convicted in a case tied to the US opioid crisis, when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller.

A federal jury in Boston found John Kapoor, the drugmaker's former chairman, and his co-defendants guilty of racketeering conspiracy for engaging in a scheme that also misled insurers into paying for the drug.

Kapoor’s 2017 arrest came on the same day US President Donald Trump declared the epidemic that has caused tens of thousands of overdose deaths annually a public health emergency.

Kapoor, 76, was found guilty of running a wide-ranging scheme to bribe doctors nationwide by retaining them to act as speakers at sham events at restaurants ostensibly meant to educate clinicians about its fentanyl spray, Subsys.

Prosecutors said Kapoor also directed efforts to defraud insurers who were reluctant to pay for Subsys. His co-defendants were former Insys executives and managers Michael Gurry, Richard Simon, Sunrise Lee and Joseph Rowan.

They face up to 20 years in prison. They denied wrongdoing, and defense lawyers signaled plans to appeal.

"Dr. Kapoor is disappointed in the verdict, as are we," Beth Wilkinson, Kapoor's lead attorney, said in a statement. "Four weeks of jury deliberations confirm that this was far from an open-and-shut case."

The US Food and Drug Administration approved Subsys in 2012 only for use in treating severe cancer pain. Yet prosecutors claimed doctors who took bribes often prescribed Subsys to patients without cancer, helping boost sales for Chandler, Arizona-based Insys.

Fentanyl is an especially potent opioid, 100 times stronger than morphine.

Kapoor's lawyers acknowledged Insys paid doctors but contended he believed they were being legally paid to discuss Subsys' benefits.

Wilkinson in her opening statement in January told jurors Kapoor had no knowledge of "side deals" being cut with doctors. She said a former executive turned government witness, Alec Burlakoff, kept Kapoor in the dark about them.

Burlakoff, Insys' ex-vice president of sales, and Michael Babich, its former chief executive, testified against Kapoor after pleading guilty to participating in the scheme.

Jurors during the trial watched a rap video Insys produced for its sales staff describing its strategies to boost sales that starred Burlakoff dressed as a dancing bottle of Subsys.

Witnesses also testified that Lee, an ex-stripper turned Insys regional sales director, gave a lap dance to a doctor at a Chicago club while pushing him to prescribe Subsys.

Insys in August said it had agreed to pay at least $150 million in a related settlement with the U.S. Justice Department. In a statement on Thursday, it said the case involved "the actions of a select few former employees."​

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Read full article
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp
Most Active
Company Price Change %Gain
Yes Bank 47.40 15.47
Indiabulls Hsg 197.95 14.39
Reliance 1,396.50 1.76
SBI 265.45 3.67
Zee Entertain 264.45 1.85
Company Price Change %Gain
Yes Bank 47.40 15.19
Indiabulls Hsg 197.15 14.03
RBL Bank 289.85 12.32
Tata Motors 138.15 9.82
HUL 2,107.80 1.74
Top Gainers
Company Price Change %Gain
Yes Bank 47.40 15.47
Tata Motors 139.50 10.85
Eicher Motors 20,491.85 6.61
IndusInd Bank 1,340.10 5.15
SBI 265.45 3.67
Company Price Change %Gain
Yes Bank 47.40 15.19
Tata Motors 138.15 9.82
IndusInd Bank 1,339.80 5.13
SBI 265.45 3.73
Bajaj Auto 3,110.30 2.96
Top Losers
Company Price Change %Gain
Vedanta 148.30 -1.07
Grasim 724.55 -0.86
TCS 2,030.95 -0.75
HCL Tech 1,093.05 -0.71
UltraTechCement 4,260.45 -0.58
Company Price Change %Gain
HCL Tech 1,089.45 -1.04
Vedanta 148.15 -1.04
Power Grid Corp 197.70 -0.50
Kotak Mahindra 1,601.00 -0.31
Infosys 769.10 -0.30

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results